International Conference on

Clinical Research

clinical research-2021

Theme: Emphasizing the safety and effectiveness of health and Medical Products

International Conference on Clinical Research

Theme: Emphasizing the safety and effectiveness of health and Medical Products

We take great pride and pleasure in inviting to the upcoming “International Conference on Clinical Research” which will be held on Toronto, Canada during November 17-18, 2021.

Clinical Research 2021 glance the various sectors starting from Drug Development, Clinical Research, Clinical Trials, Observational studies, Pharmaceuticals, Contract Research Organizations, Public Health Sectors, Epidemiology, Clinical Toxicology, Clinical Pharmacology. Clinical Research 2021 is a conference designed for the renowned experts working in the field of Clinical Trials & Pharmacology will focus on the Patient Centric Clinical trials, Oncology trials, Drug design, Adaptive clinical trials experience done in the related area of Clinical Trials, Pharmacovigilance, Translational medicine, Epidemiology. Two days interactive, stimulating discussion and presentations on clinical research, pharmaceutics, pharmacology, Cancer and Pharmacovigilance and latest research findings that can help you establish a different learning approach using evidence-based practice for better results. It includes prompt keynote presentations, poster presentations, oral talks, exhibitions and Special Sessions.

“Special Session Topic: Impact of Covid-19 on clinical research & trials”




Clinical Research and Clinical Trials

Clinical research is the study of health and illness in people. It is the way we learn how to prevent, diagnose and treat illness. Clinical research describes many different elements of scientific investigation. Simply put, it involves human participants and helps translate basic research (done in labs) into new treatments and information to benefit patients. A clinical trial is an experiment designed to answer specific questions about possible new treatments or new ways of using existing (known) treatments. Clinical trials are done to determine whether new drugs or treatments are safe and effective.

Drug Discovery and Development

Drug discovery is a process which aims at identifying a compound therapeutically useful in curing and treating disease. This process involves the identification of candidates, synthesis, characterization, validation, optimization, screening and assays for therapeutic efficacy. New drug development process must continue through several stages in order to make a medicine that is safe, effective, and has approved all regulatory requirements. One overall theme of our article is that the process is sufficiently long, complex, and expensive so that many biological targets must be considered for every new medicine ultimately approved for clinical use and new research tools may be needed to investigate each new target.

Clinical Research Informatics

Clinical research is critical to the advancement of medical science and public health.Clinical research informatics is the rapidly evolving sub-discipline within biomedical informatics that focuses on developing new informatics theories, tools, and solutions to accelerate the full translational continuum: basic research to clinical trials (T1), clinical trials to academic health center practice (T2), diffusion and implementation to community practice (T3), and 'real world' outcomes (T4).

Biomedical Devices Clinical Research

Medical device clinical trials are fundamental to international mandates for product safety. Consequently, attention to this topic is required to ensure that the safety of the general population is a high priority in order for new devices for diagnosis, treatment and rehabilitation to reach the market. Both industry innovation and regulation collaborate to provide devices for emerging markets and to improve on existing devices. This chapter introduces the mandatory procedures and marketing submission process for the United States and the European Union. The general regulatory profiles of these two leading medical device producers/consumers are important because the US Market segment accounts for more than 50% and the EU for about 30% of the world’s growing $300+ billion dollar market.

Clinical and Medical Case Reports

Case reports offer unique value to the body of medical knowledge by describing new diseases, disease mechanisms, therapeutic approaches, and adverse or beneficial effects of drugs. The act of recording, discussing with colleagues, and publishing clinical observations as case reports remains essential to the art of medicine and patient care. The merits of large randomized studies are well known, but many clinicians recognize the value of case reports as a complement to evidence-based medicine. As scientific publishing shifts from a business model of subscription revenue to open access, the number of open access journals has exploded.

Pharmacovigilance and Drug Safety

Pharmacovigilance is like a sunshade to describe the processes for monitoring and evaluating ADRs and it is a key component of effective drug regulation systems, clinical practice and public health programmes. The number of Adverse Drug Reactions (ADRs) reported resulted in an increase in the volume of data handled, and to understand the pharmacovigilance, a high level of expertise is required to rapidly detect drug risks as well as to defend the product against an inappropriate removal. Drug safety and pharmacovigilance remains a dynamic clinical and scientific discipline. Pharmacovigilance is defined by the World Health Organization (WHO) as ’the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other drug-related problem.

Oncology Clinical Research

Oncology is defined as the branch of medicine that deals with the study and treatment of cancer. Growing up, it was every mother’s dream that their child would someday discover the cure for cancer. Thanks to advances in science and technology, some of those dreams have become a reality. Clinical trials to test new cancer treatments involve a series of steps, called phases. There are 3 main phases of clinical trials. If a new treatment is successful in one phase, it will move on to further testing in the next phase. A drug or device usually has to demonstrate success in the first 3 phases before it is approved by the FDA for broader use. However, the FDA also has a number of programs to support faster development and review of new drugs for areas of unmet medical need, like lung cancer.

Clinical Nursing Research

Nursing is the art and science that involves working with individual, families, and communities to promote wellness of body, mind, and spirit. It is a dynamic, therapeutic and educational process that serves to meet the health needs of the society, including its most vulnerable members. Although most clinical research in nursing focus on quantitative designs, qualitative research designs similarly play an important role in clinical nursing studies. How qualitative research is described varies in different fields, but an over aching theme is that qualitative research is research focusing on how individuals (or groups) view and understand their world and experiences.

Post-marketing Surveillance

Post-marketing surveillance (PMS) to assure the quality, efficacy and safety of drugs after they go on the market and to establish proper methods of use of drugs consists of three systems: the ADRs and infections collection and reporting system, the reexamination system, and the reevaluation system. To market a drug, the manufacturer must provide evidence of its efficacy and safety to the U.S. Food and Drug Administration (FDA) and specified Regulatory Authorities. In premarketing testing, the numbers and types of patients used to demonstrate a drug’s efficacy and safety are limited compared with the numbers and types of patients who will eventually be prescribed the drug after it is marketed. Although post-marketing surveillance cannot provide knowledge of the safety or efficacy of thugs at the time of their introduction on the market, Post-marketing surveillance of drug therefore play an important role to discover an undesirable effect that might present at risk. It provides additional information on the benefits and risk of the drugs.

Clinical Research in psychiatrist

There are multiple models of mental illness that inform professional and lay understanding. Few studies have formally investigated psychiatrists' attitudes. We aimed to measure how a group of trainee psychiatrists understand familiar mental illnesses in terms of propositions drawn from different models. Method: We used a questionnaire study of a sample of trainees from South London and Maudsley National Health Service (NHS) Foundation Trust designed to assess attitudes across eight models of mental illness (e.g. biological, psychodynamic) and four psychiatric disorders. Methods for analysing repeated measures and a principal components analysis (PCA) were used. Results: No one model was endorsed by all respondents. Model endorsement varied with disorder. Attitudes to schizophrenia were expressed with the greatest conviction across models. 

Clinical Study Designs

In clinical research, our aim is to design a study which would be able to derive a valid and meaningful scientific conclusion using appropriate statistical methods. The conclusions derived from a research study can either improve health care or result in inadvertent harm to patients. Hence, this requires a well‐designed clinical research study that rests on a strong foundation of a detailed methodology and governed by ethical clinical principles. The purpose of this review is to provide the readers an overview of the basic study designs and its applicability in clinical research.




The growing prevalence of diseases along with the rising incidence of new diseases is driving market growth. Also, increasing investments on new product development, such as personalized medicine and evolution in technology in emerging countries is fuelling market growth. However, budget constraints of small and medium-sized pharmaceutical and biotechnology companies are expected to restrain the market growth. This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of clinical trials. Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for clinical trials in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.

The clinical trials market is projected to arrive at USD 1.76 billion by 2025, from USD 1.04 billion in 2017 growing at a CAGR of 6.7 percent from 2018 to 2025. An upcoming market report contains data for historic year 2016, and the base year of calculation is 2017. Data Bridge Market Research has announced the availability of Clinical Trials Market Outlook to 2025. The global industry report, which covers key players such as PAREXEL, LabCorp, ICON plc, Novo Nordisk, and Covance, provides insights, market dimensions and evaluations for the period from 2018 to 2025.

The research study provides far-reaching investigation of numerous global clinical trials industry segments in terms of applications, product components and services and geographical regions. The market report covers data points for 28 countries and addresses the global perspective of clinical trials industry with regional splits into North America, Europe, China, Japan, Southeast Asia, India, Asia Pacific and Middle East.

  • Clinical Research and Clinical Trials
  • Drug Discovery and Development
  • Clinical Research Informatics
  • Biomedical Devices Clinical Research
  • Clinical and Medical Case Reports
  • Pharmacovigilance and Drug Safety
  • Oncology Clinical Research
  • Clinical Nursing Research
  • Post-marketing Surveillance
  • Clinical Research in psychiatrist
  • Clinical Study Designs

Media Partners & Collaborations

Media Partner

Media Partner